Apatinib Plus Chemotherapy as Second-Line Treatment in Unresectable NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Oncologist
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Apatinib Plus Chemotherapy as a Second-Line Treatment in Unresectable Non-Small Cell Lung Carcinoma: A Randomized, Controlled, Multicenter Clinical Trial
Oncologist 2020 Jun 13;[EPub Ahead of Print], Z Yu, Z Xu, Z He, J Lai, W Wang, J Zhang, W Kong, X Huang, Y Chen, Y Shi, X Shi, Z Zhao, M Ni, X Lin, S Chen, X Wu, W Chen, Z Song, C HuangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.